Fiocruz

GemmaBio Secures $34 Million in Funding

Gemma Biotherapeutics (GemmaBio), a new therapeutics company founded by gene therapy pioneer Jim Wilson, recently announced the completion of a $34 million seed funding round to accelerate its groundbreaking gene therapy initiatives.

Topics • Strategy

Opportunities Through Biotechnology

Top-Feature

Dow Chemical Company

Industry Kick-Off with Signal Effect: More Than 310 Exhibitors expected at maintenance and PUMPS & VALVES 2026

WuXi AppTec

Europe’s Biotech Inflection Point

Special Issue

Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Gemma Biotherapeutics

Thomson Reuters

Fiocruz

GemmaBio Secures $34 Million in Funding

Opportunities Through Biotechnology

Top-Feature

Anchored in Sustainability

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Brenntag Downsizes Management Board, Retains Both Divisions

API Manufacturing

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Driving Sustainability Through Collaboration

Leading Transformation

Leading the way. Driving results.

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Industry Kick-Off with Signal Effect: More Than 310 Exhibitors expected at maintenance and PUMPS & VALVES 2026

Europe’s Biotech Inflection Point

Special Issue

Circular Plastics Economy

Newsletter & e-edition